salmeterol xinafoate - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
PAVTIDE ACCUHALER 250/50 fluticasone propionate 250 microgram/salmeterol (as xinafoate) 50 microgram powder for inhalation blister pack AUST R: 208201Active ingredients:
fluticasone propionate
salmeterol xinafoate
Dosage form:
Inhalation, powder for
Sponsor:
GlaxoSmithKline Australia Pty Ltd
Phone:
1800033109
|
From
22 Aug 2025
to
20 Oct 2025
|
Shortage status:
Resolved
Availability:
Available
Reason:
Unexpected increase in consumer demand
|
PAVTIDE MDI 125/25 fluticasone propionate 125 mcg/salmeterol (as xinafoate) 25 mcg inhalation pressurised aerosol can metered dose (with counter) AUST R: 208670Active ingredients:
fluticasone propionate
salmeterol xinafoate
Dosage form:
Inhalation, pressurised
Sponsor:
GlaxoSmithKline Australia Pty Ltd
Phone:
1800033109
|
From
15 Sep 2025
to
23 Sep 2025
|
Shortage status:
Resolved
Availability:
Available
Reason:
Unexpected increase in consumer demand
|